Log in
Microbiology · Oncogenic viruses

DNA-containing oncogenic viruses

DNA-containing oncogenic viruses are capable of causing malignant transformation of infected tissues. Instead of the typical destruction of the host cell, they trigger a process of irreversible transformation by blocking the cell's natural defense mechanisms against tumor growth.

Cell typeOncogenesis predominantly occurs in non-permissive cells
GeneticsThe key stage of transformation is the expression of early viral genes
TargetsViruses inactivate the products of antioncogenes (tumor suppressor proteins p53 and Rb)
4 min readFor medical studentsUpdated Sep 25, 2026
Material prepared by WhiteCoat Pro editorial team based on platform study guidesReviewed by medical editor: Aulov A. A., general practitioner · 09/24/2026

Features of interaction with the cell and T-antigens

Normally, viruses penetrate a cell, replicate within it, and cause its death (lysis). However, oncogenesis follows a completely different scenario. This process typically occurs in so-called non-permissive cells. In such structures, for various reasons, the virus cannot fully replicate its genome and produce new mature virions.

Since lysis does not occur, the cell survives. Instead, its malignant transformation begins. The key stage of this pathological process is the expression of early viral genes. The protein products synthesized based on these genes are called T-antigens (from the Latin term tumor). In most cases, T-antigens are localized directly within the cell nucleus, but in rarer situations, they can also embed into the cell membrane, disrupting normal functioning.

Interaction with cellular suppressors

In a healthy organism, there are strict regulatory mechanisms preventing uncontrolled division. Specific cellular tumor suppressor proteins, which are products of antioncogenes, are responsible for this control. The primary mechanism of viral oncogenesis by DNA viruses lies in the targeted inactivation of these crucial protective proteins.

The main targets for viral T-antigens are two proteins:

  • p53 protein — a crucial phosphoprotein that acts as the main tumor suppressor.
  • Rb protein — a protein named after the disease retinoblastoma, whose function is to strictly control cell proliferation. Viruses severely disrupt its normal operation.
Test your knowledge on this topicAssignments from the Microbiology course bank — instant answers and explanations.

The p53 cascade and its viral blockade

To fully understand the danger of oncogenic viruses, it is necessary to examine the normal function of the p53 phosphoprotein in detail. In an uninfected cell, it operates according to the following algorithm:

  1. Upon any physical or chemical DNA damage, the synthesis of the p53 protein instantly increases.
  2. The accumulated p53 acts as a factor that activates the transcription of another important protein — WAFI.
  3. The WAFI protein binds cellular cyclins and completely inactivates them.
  4. As a result, the cell cycle is forcibly halted, giving enzymes time to repair damaged DNA.
  5. If repair is successful, the level of p53 drops sharply, and normal cell division resumes.

What happens during viral oncogenesis? Viral proteins interfere with this process and tightly block the p53 phosphoprotein. Because of this, the defense cascade is not triggered: the cell cycle does not stop, and repair is not carried out. The virus allows active division of cells with already damaged genomes, which inevitably leads to tumor formation.

Briefly: answers to topical questions

Which families of DNA-containing viruses are considered oncogenic?

The family Papillomaviridae possesses oncogenic potential: papillomaviruses infect the skin and mucous membranes, induce epithelial proliferation, and can cause dysplasia and cancer. The classification of the other listed families as oncogenic is not covered in the provided materials.

Which specific oncoproteins of the human papillomavirus (HPV) inactivate p53 and Rb?

The p53 and Rb proteins are inactivated by early functional proteins of the human papillomavirus.

These oncoproteins include:

  • E6 protein — an early gene product, serving as a marker of oncogenicity.
  • E7 protein — an early gene product, also acting as a marker of oncogenicity.

These viral proteins inactivate tumor suppressor genes, leading to a loss of cell cycle control and uncontrolled cellular proliferation.

How does the interaction of an oncogenic virus with a permissive cell differ from that with a non-permissive cell?

In a permissive cell, a productive infection develops: a full replication cycle occurs, and infectious progeny are formed. In a non-permissive cell, the virus cannot fully replicate and form new virions; instead of lysis, cell transformation associated with oncogenesis occurs.

How to memorize

Imagine a cell as a car. The p53 and Rb proteins are reliable brakes. Viral T-antigens (Tumor) cut the brake lines (inactivate the suppressors). The car can no longer stop for "repairs" (DNA repair) and rushes at full speed into the abyss of uncontrolled division.

Class and exam questions

Why does malignant transformation occur specifically in non-permissive cells?

In non-permissive cells, the virus is physically incapable of completing the replication cycle and assembling new virions. Therefore, classic cell lysis (destruction) does not occur, and early viral genes manage to trigger the transformation process of the surviving cell.

What are T-antigens and where are they located?

T-antigens are protein products of early viral gene expression responsible for tumor transformation (from the word tumor). They are predominantly located inside the cell nucleus, but are sometimes found on the cell membrane.

What is the role of the WAFI protein in protecting the cell against oncogenesis?

The WAFI protein, the synthesis of which is activated by the p53 phosphoprotein upon DNA damage, binds and inactivates cyclins. This leads to a temporary arrest of the cell cycle, giving time to repair damaged genetic material.

Something unclear? Ask the AIThe AI tutor has reviewed the material on "DNA-containing oncogenic viruses" and will explain it in simple terms.

What else to study on this topic

  • Mechanisms of DNA virus replication in permissive cells
  • Molecular structure and functions of the p53 phosphoprotein
  • The role of cyclins in cell cycle regulation
  • The process of WAFI protein transcription
  • Rb protein: pathogenesis of retinoblastoma development

Study the full topic in the «Microbiology» course

This is a summary. The course covers everything tested in classes and exams.

  • Complete study guide on "DNA-containing oncogenic viruses" and 4,383 more subject pages
  • Assignments and quizzes after every topic — just like in a colloquium
  • AI tutor answers questions on the topic anytime
  • 141 video lectures on the subject

Other topics in the "Oncogenic viruses" section

Entire section "Oncogenic viruses"

Free video lessons: microbiologyShort lessons with study notes — no registration required.

Watch lessons

Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.